
Merck & Co (US)


Merck is one of the world's leading pharmaceutical
companies, with a portfolio currently led by asthma treatment Singulair. The group has struggled against multiple setbacks
in recent years, the most serious of which were the repercussions from defects in its blockbuster arthritis medicine
Vioxx. Merck withdrew that product in 2004 after publication of a report which demonstrated that it increased the risk of
heart attacks in some patients. A series of lawsuits ensued, although for the most part Merck was exonerated of any fault
and later announced a settlement to cover all subsequent suits. As if that were not enough to contend with, the company's
flagship product Zocor lost its patent in 2006, and Merck seemed to have comparatively few other blockbusters in its
pipeline. Yet the company has made a dynamic recovery since then, turning what appeared to be a clutch of minor vaccines
into what could now be substantial new products. In 2009 it announced plans to acquire smaller competitor Schering-Plough.
The two companies are already partners in a global asthma and anti-cholesterol joint venture. Advertising Age
estimated global measured advertising expenditure of $395m in 2007, making Merck the world's #88 advertiser.
Click here to access the Adbrands profile (subscribers only);
or subscribe to Adbrands.net here. Adbrands Company Profiles provide a
detailed analysis of the history and current operations of leading advertisers, agencies and brands worldwide, and include a
critical summary which identifies key strengths and weaknesses. Adbrands Account Assignments tracks account management for
the world's leading brands and companies, including details of which advertising agency handles which accounts in which
countries for major markets..
Advertising: Which agencies handle advertising for Merck? The searchable account assignments database is
available to full subscribers to Adbrands.net premium services. Click here for subscription
information.
Competitors: see also Pharmaceutical Sector index for
competitive companies


Subscribers may access the following website links:
Merck website

Crixivan |
Vioxx |
Fosamax |
Zocor |
Maxalt |
Cozaar |
Propecia |
Merck Vaccines |
Proscar |
Merial |
Zetia |
Singulair |

Merck Sharp & Dohme |
Banyu Pharmaceutical |
Click HERE to subscribe to
Adbrands.net and access the profile and website links
Adbrands.net.
All rights reserved © Mind Advertising Ltd 1998-2009
|